Cargando…
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321428/ https://www.ncbi.nlm.nih.gov/pubmed/34332707 http://dx.doi.org/10.1016/S1473-3099(21)00420-5 |
| _version_ | 1783730847971540992 |
|---|---|
| author | Tenbusch, Matthias Schumacher, Sofie Vogel, Emanuel Priller, Alina Held, Jürgen Steininger, Philipp Beileke, Stephanie Irrgang, Pascal Brockhoff, Ronja Salmanton-García, Jon Tinnefeld, Kathrin Mijocevic, Hrvoje Schober, Kilian Bogdan, Christian Yazici, Sarah Knolle, Percy Cornely, Oliver A Überla, Klaus Protzer, Ulrike |
| author_facet | Tenbusch, Matthias Schumacher, Sofie Vogel, Emanuel Priller, Alina Held, Jürgen Steininger, Philipp Beileke, Stephanie Irrgang, Pascal Brockhoff, Ronja Salmanton-García, Jon Tinnefeld, Kathrin Mijocevic, Hrvoje Schober, Kilian Bogdan, Christian Yazici, Sarah Knolle, Percy Cornely, Oliver A Überla, Klaus Protzer, Ulrike |
| author_sort | Tenbusch, Matthias |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8321428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83214282021-07-30 Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 Tenbusch, Matthias Schumacher, Sofie Vogel, Emanuel Priller, Alina Held, Jürgen Steininger, Philipp Beileke, Stephanie Irrgang, Pascal Brockhoff, Ronja Salmanton-García, Jon Tinnefeld, Kathrin Mijocevic, Hrvoje Schober, Kilian Bogdan, Christian Yazici, Sarah Knolle, Percy Cornely, Oliver A Überla, Klaus Protzer, Ulrike Lancet Infect Dis Correspondence Elsevier Ltd. 2021-09 2021-07-29 /pmc/articles/PMC8321428/ /pubmed/34332707 http://dx.doi.org/10.1016/S1473-3099(21)00420-5 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Tenbusch, Matthias Schumacher, Sofie Vogel, Emanuel Priller, Alina Held, Jürgen Steininger, Philipp Beileke, Stephanie Irrgang, Pascal Brockhoff, Ronja Salmanton-García, Jon Tinnefeld, Kathrin Mijocevic, Hrvoje Schober, Kilian Bogdan, Christian Yazici, Sarah Knolle, Percy Cornely, Oliver A Überla, Klaus Protzer, Ulrike Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title | Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title_full | Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title_fullStr | Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title_full_unstemmed | Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title_short | Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 |
| title_sort | heterologous prime–boost vaccination with chadox1 ncov-19 and bnt162b2 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321428/ https://www.ncbi.nlm.nih.gov/pubmed/34332707 http://dx.doi.org/10.1016/S1473-3099(21)00420-5 |
| work_keys_str_mv | AT tenbuschmatthias heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT schumachersofie heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT vogelemanuel heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT prilleralina heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT heldjurgen heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT steiningerphilipp heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT beilekestephanie heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT irrgangpascal heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT brockhoffronja heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT salmantongarciajon heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT tinnefeldkathrin heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT mijocevichrvoje heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT schoberkilian heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT bogdanchristian heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT yazicisarah heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT knollepercy heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT cornelyolivera heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT uberlaklaus heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT protzerulrike heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 AT heterologousprimeboostvaccinationwithchadox1ncov19andbnt162b2 |